![](/img/cover-not-exists.png)
An Open-Label Phase 2 Study of Carfilzomib plus Dexamethasone to Assess Tolerability and Adherence in Patients with Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Fonseca, Rafael, Alsina, Melissa, Berdeja, Jesus, Heitner, Stephen B., Morris, Christopher, Khurana, Monica, Niesvizky, RubenVolume:
18
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2018.07.131
Date:
September, 2018
File:
PDF, 93 KB
english, 2018